Nihong Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Inflammasome and immune disorders
Papers in
-
- Natural product bioactivities and synthesis 3
- RNA modifications and cancer 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
- Co-authors
- Ruiwei Guo (3 shared papers)Xianmei Wang (2 shared papers)Lixia Yang (2 shared papers)Yan-Kun Shi (2 shared papers)Yanni Yang (1 shared paper)Ting Li (1 shared paper)Zhengkun Li (1 shared paper)Wenlin Tai (1 shared paper)
In The Last Decade
Nihong Lu
16 papers receiving 363 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 197
- Molecular Biology 252
- Pulmonary and Respiratory Medicine 108
- Immunology 39
- Nephrology 13
Countries citing papers authored by Nihong Lu
This map shows the geographic impact of Nihong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nihong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nihong Lu more than expected).
Fields of papers citing papers by Nihong Lu
This network shows the impact of papers produced by Nihong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nihong Lu. The network helps show where Nihong Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Nihong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 139 | |
| 2 | 2018 | 106 | |
| 3 | 2019 | 33 | |
| 4 | 2017 | 19 | |
| 5 | 2018 | 17 | |
| 6 | 2019 | 17 | |
| 7 | 2021 | 9 | |
| 8 | 2018 | 6 | |
| 9 | 2020 | 5 | |
| 10 | 2018 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2018 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2023 | 0 |
About Nihong Lu
Nihong Lu is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Toxicology and Surgery, having authored 18 papers that have together received 364 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Natural product bioactivities and synthesis (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), MicroRNA in disease regulation (2 papers), Tuberculosis Research and Epidemiology (2 papers), RNA modifications and cancer (2 papers), Estrogen and related hormone effects (2 papers) and Biological Stains and Phytochemicals (2 papers). The work is most often cited by research in Cancer Research (197 citations), Molecular Biology (252 citations), Pulmonary and Respiratory Medicine (108 citations), Immunology (39 citations) and Nephrology (13 citations). Nihong Lu has collaborated with scholars based in China, Thailand and Czechia. Frequent co-authors include Ruiwei Guo, Xianmei Wang, Lixia Yang, Yan-Kun Shi, Yanni Yang, Ting Li, Zhengkun Li, Wenlin Tai, Tao Zhang and Yongjun Liu. Their work appears in journals such as RSC Advances, Biochemical and Biophysical Research Communications, Pharmacology, Microbial Pathogenesis and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.